GSA Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,208
| Closed | -$1.22M | – | 2074 |
|
|
2023
Q1 | $1.22M | Buy |
+11,208
| New | +$1.22M | 0.12% | 223 |
|
|
2022
Q4 | – | Sell |
-9,824
| Closed | -$608K | – | 2047 |
|
|
2022
Q3 | $608K | Buy |
9,824
+4,212
| +75% | +$261K | 0.08% | 432 |
|
|
2022
Q2 | $448K | Sell |
5,612
-3,770
| -40% | -$301K | 0.07% | 567 |
|
|
2022
Q1 | $987K | Buy |
9,382
+5,059
| +117% | +$532K | 0.13% | 186 |
|
|
2021
Q4 | $466K | Buy |
4,323
+2,068
| +92% | +$223K | 0.06% | 647 |
|
|
2021
Q3 | $247K | Buy |
+2,255
| New | +$247K | 0.03% | 1129 |
|
|
2020
Q1 | – | Sell |
-6,401
| Closed | -$232K | – | 1788 |
|
|
2019
Q4 | $232K | Buy |
+6,401
| New | +$232K | 0.03% | 1181 |
|
|
2019
Q3 | – | Sell |
-10,853
| Closed | -$261K | – | 1903 |
|
|
2019
Q2 | $261K | Sell |
10,853
-41,702
| -79% | -$1M | 0.03% | 1090 |
|
|
2019
Q1 | $1.39M | Sell |
52,555
-1,145
| -2% | -$30.3K | 0.14% | 148 |
|
|
2018
Q4 | $1.05M | Sell |
53,700
-17,400
| -24% | -$340K | 0.12% | 197 |
|
|
2018
Q3 | $1.39M | Buy |
+71,100
| New | +$1.39M | 0.08% | 463 |
|
|
2017
Q1 | – | Sell |
-35,920
| Closed | -$581K | – | 2131 |
|
|
2016
Q4 | $581K | Buy |
35,920
+17,506
| +95% | +$283K | 0.03% | 898 |
|
|
2016
Q3 | $334K | Buy |
+18,414
| New | +$334K | 0.02% | 1301 |
|
|
2016
Q2 | – | Sell |
-16,803
| Closed | -$278K | – | 2003 |
|
|
2016
Q1 | $278K | Sell |
16,803
-9,472
| -36% | -$157K | 0.02% | 1338 |
|
|
2015
Q4 | $569K | Sell |
26,275
-231,831
| -90% | -$5.02M | 0.03% | 1077 |
|
|
2015
Q3 | $5.12M | Buy |
258,106
+200,969
| +352% | +$3.98M | 0.25% | 43 |
|
|
2015
Q2 | $1.99M | Buy |
57,137
+27,927
| +96% | +$970K | 0.08% | 378 |
|
|
2015
Q1 | $759K | Buy |
+29,210
| New | +$759K | 0.03% | 1093 |
|
|
2014
Q1 | – | Sell |
-34,200
| Closed | -$261K | – | 1903 |
|
|
2013
Q4 | $261K | Buy |
+34,200
| New | +$261K | 0.02% | 1309 |
|